Medico Remedies Ltd (MEDICO) is currently trading at 35.25 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Medico Remedies Limited is a pharmaceutical company specializing in manufacturing and marketing pharmaceutical formulations. Their expertise includes anti-infective, antimalarial, and cardiovascular drugs among other categories. The company's manufacturing facilities are ISO 9001:2015 certified and have WHO-GMP accreditation, indicating high quality and compliance with international standards. Medico Remedies has successfully expanded its manufacturing capabilities over the decades, with significant infrastructural expansions in 1999, 2002, and 2018-19 at its facilities in Maharashtra. The company maintains strong relationships with its clients, supplying both Indian and international pharmaceutical firms, showcasing its global operational reach. In January 2018, Medico Remedies raised significant equity capital through a public issue, marking a milestone in its financial strategy to support further growth.

Over the past 52 weeks, Medico Remedies Ltd has traded between a low of ₹31.00 and a high of ₹56.99. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Medico Remedies Ltd has a market capitalization of approximately 328.45. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Medico Remedies Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 23.77 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 328.45 Cr, Medico Remedies Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Medico Remedies Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Medico Remedies Ltd is 23.77. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.